Hyperparathyroidism, Secondary - 21 Studies Found Completed : Safety, Tolerability and Pharmacokinetics of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism : Hyperparathyroidism, Secondary : 2010-05-28 : Drug: Saline Single IV injecti Completed : Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis : Hyperparathyroidism, Secondary : 2013-02-05 : Drug: Etelcalcetide Administered by bolus injection into the venous line of the dialysis circuit at the Completed : Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis : Hyperparathyroidism, Secondary : 2013-02-05 : Drug: Etelcalcetide Administer Completed : Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis : Hyperparathyroidism, Secondary : 2013-02-07 : Drug: Etelcalcetide Administer Completed : Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis : Hyperparathyroidism, Secondary : 2010-08-12 : Drug: Traditional Vitamin D Therapy Active, not recruiting : To Assess the Long-term Safety of AMG 416 in the Treatment of SHPT in Subjects With CKD on Hemodialysis : Hyperparathyroidism, Secondary : 2014-03-03 : Drug: AMG 416 Subjects will be administered IV AMG 416 at the end of their regular dialysis sessions on Completed : Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism : Secondary Hyperparathyroidism : 2010-12-03 : Drug: Etelcalcetide Administer Completed : Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT) : Secondary Hyperparathyroidism : 2009-01-22 : Drug: 1.0 μg/day Alfacalcidol Completed : Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients : Secondary Hyperparathyroidism : 2015-01-11 : Drug: Combination Cinacalcet with Vitamin D analogue Depending on the iPTH level and the serum calcium l Completed : LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients : Secondary Hyperparathyroidism : 2010-07-02 : Drug: LEO 27847 First in patient Next >>>
